Billionaire Profile
Christian Boehringer
Global Rank
#605

Image: Unknown authorUnknown author | Public domain | via Wikimedia Commons

Christian Boehringer

CEO, Pharmaceuticals
GERMANY
Real-Time Net Worth
$6.538B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
0% (24h)
Age
60
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
GERMANY

Biography

Christian Boehringer is a prominent figure in the pharmaceutical industry, owing his fortune to Germany's Boehringer Ingelheim, a world-leading privately-owned pharmaceutical company. As of February 2026, his net worth is estimated to be $5.9 billion. Boehringer, along with 14 members of his family, owns equal parts of the company. He served as chairman of the shareholders' committee of Boehringer Ingelheim from 2007 to 2025, representing the interests of the owning families. Boehringer Ingelheim, founded in 1885, has a presence in 130 markets and employs over 53,000 people. The company is known for its innovative medicines that treat a variety of diseases, including COPD, anti-coagulation, and type 2 diabetes.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Christian Boehringer was born in Wiesbaden, Germany, in 1965. He is a member of the fourth generation of the Boehringer family, who own Boehringer Ingelheim, a leading pharmaceutical company.

Rise to Success

Boehringer's career includes experience as a pharmaceutical product manager at Boehringer Ingelheim in Great Britain and later as a leader of a European pharmaceutical consulting firm. He also spent time in international management at Henkel KGaA before returning to Boehringer Ingelheim. He then took on the responsibility for global CRM project management and later became an Area Manager, responsible for the USA, Canada, and Mexico.

Key Business Strategies

Boehringer's influence is primarily through his role as Chairman of the Shareholders' Committee of Boehringer Ingelheim, which represents the interests of the owning families. Boehringer Ingelheim is known for its long-term focus, allowing them to focus on long-term goals, such as scientific progress over personal visibility, without the pressures of the public markets. The company's key areas of interest are respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system.

Philanthropy

Boehringer is involved in various initiatives that support equal opportunities in education and the preservation of handwriting.

Career Milestones

2000

International Management at Henkel KGaA

Worked in the international management of Henkel KGaA in Düsseldorf for three years.

2007-2025

Chairman of the Shareholders' Committee

Served as Chairman of the Shareholders' Committee of Boehringer Ingelheim, representing the interests of the owner families.

Philanthropy & Social Impact

Education

Educational Initiatives

Undisclosed

Supports initiatives for more equal opportunities in education.

Culture

Preservation of Handwriting

Undisclosed

Supports initiatives for the preservation of handwriting.